Detalhe da pesquisa
1.
Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-triazine derivative (XIN-9): A novel potent dual PI3K/mTOR inhibitor for cancer therapy.
Bioorg Chem
; 129: 106157, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36209563
2.
Design, synthesis and biological evaluation of substituted 2-(thiophen-2-yl)-1,3,5-triazine derivatives as potential dual PI3Kα/mTOR inhibitors.
Bioorg Chem
; 95: 103525, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31887474
3.
Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3Kα Inhibitors.
Molecules
; 24(19)2019 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31547116
4.
Corrigendum to "Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-triazine derivative (XIN-9): A novel potent dual PI3K/mTOR inhibitor for cancer therapy" [Bioorg. Chem. 129 (2022) 106157].
Bioorg Chem
; 131: 106336, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36587506
5.
Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors.
Molecules
; 23(7)2018 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954109
6.
Synthesis and Structure-Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold.
Molecules
; 22(11)2017 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29088090
7.
From polymerase engineering to semi-synthetic life: artificial expansion of the central dogma.
RSC Chem Biol
; 3(10): 1173-1197, 2022 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36320892
8.
Synthesis and bioevaluation of thienopyrimidines bearing a pyrazoline unit as selective PI3Kα inhibitors.
RSC Adv
; 9(51): 29579-29589, 2019 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35531514